菲律宾肿瘤学药物价格指南 | 比较特药费用
Philippines Oncology Medicine Price Guide
If you’re searching for oncology medicine prices in the Philippines, this guide helps you compare common branded search terms with available generic sourcing options.
Our team provides verified quotation support based on prescription, required dose, and current supply conditions.
Oncology Medicine Price Indicator Table
| Molecule / Common Search Query | PH Retail Indicator Range* | Generic Sourcing Indicator Range* | Potential Savings* |
|---|---|---|---|
| Tagrisso / Osimertinib | ₱140,000–₱210,000 | ₱28,000–₱65,000 | Up to ~70% |
| Lenvima / Lenvatinib | ₱95,000–₱155,000 | ₱22,000–₱58,000 | Up to ~65% |
| Nexavar / Sorafenib | ₱75,000–₱120,000 | ₱18,000–₱45,000 | Up to ~60% |
*Guidance only; not a binding offer. Actual pricing depends on strength, manufacturer availability, and final fulfillment pathway.
How to Evaluate Oncology Medicine Pricing Safely
- Confirm molecule and dose with your oncologist
- Compare total cost per treatment cycle, not just per pack
- Verify source documentation and batch details
- Use licensed pharmacy support for procurement workflow
Frequently Asked Questions
Are generics equivalent for all patients?
Treatment choices must remain physician-led. This page does not replace medical advice.
Do you provide nationwide shipping in the Philippines?
Service coverage depends on medicine category and regulatory handling requirements.
How can I receive a formal quote?
Submit your prescription and patient requirements through the quote form.
Disclaimer: Prices shown are informational guidance only and are not binding offers. Final pricing is subject to prescription validation, stock availability, dose strength, and import fulfillment conditions. This page does not constitute medical advice. Always consult your physician for treatment decisions.
Related: Oncology • Contact Us • About IndogenMed